Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A group of neoplasms composed of T-lymphocytes with a mature (peripheral/post-thymic) immunophenotypic profile and/or NK-cells.
Biomarker and diagnostic research for neoplasm of mature T-cells or NK-cells has been reported in the published literature.
No clinical trials have been registered for neoplasm of mature T-cells or NK-cells.
319 publications have been identified in PubMed for neoplasm of mature T-cells or NK-cells. Kisho has analyzed 141 by research type. Research spans Review / Meta-Analysis (50%), Basic Science / Preclinical (29%), and Gene Therapy / Novel Therapeutics (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 70 | 50% |
Data assembled from 2 of 12 sources · Last updated Oct 3, 2026, 10:56 PM UTC
Laboratory research |
41 |
29% |
New treatment approaches | 23 | 16% |
Testing and diagnosis research | 4 | 3% |
Other research | 1 | 1% |
Clinical study results | 1 | 1% |
Disease patterns and progression | 1 | 1% |
Wang Y (2026). [PMID: 41707592](https://pubmed.ncbi.nlm.nih.gov/41707592/). *Int Immunopharmacol*. [Review / Meta-Analysis]
Wong JKM (2026). [PMID: 41338184](https://pubmed.ncbi.nlm.nih.gov/41338184/). *Mol Ther*. [Basic Science / Preclinical]
Zhou Z (2026). [PMID: 41692037](https://pubmed.ncbi.nlm.nih.gov/41692037/). *Crit Rev Oncol Hematol*. [Review / Meta-Analysis]
Cakirsoy Akyoney D (2026). [PMID: 41939884](https://pubmed.ncbi.nlm.nih.gov/41939884/). *Front Immunol*. [Review / Meta-Analysis]
Chen S (2026). [PMID: 41560319](https://pubmed.ncbi.nlm.nih.gov/41560319/). *Adv Sci (Weinh)*. [Basic Science / Preclinical]
Kong LZ (2026). [PMID: 40456445](https://pubmed.ncbi.nlm.nih.gov/40456445/). *J Adv Res*. [Gene Therapy / Novel Therapeutics]
Chen YJ (2026). [PMID: 42004956](https://pubmed.ncbi.nlm.nih.gov/42004956/). *Front Immunol*. [Review / Meta-Analysis]
Zhi L (2026). [PMID: 41650499](https://pubmed.ncbi.nlm.nih.gov/41650499/). *Exp Mol Pathol*. [Review / Meta-Analysis]
Lin P (2026). [PMID: 41144785](https://pubmed.ncbi.nlm.nih.gov/41144785/). *Blood Cancer Discov*. [Diagnostic / Biomarker]
Jin W (2026). [PMID: 41516373](https://pubmed.ncbi.nlm.nih.gov/41516373/). *Int J Mol Sci*. [Gene Therapy / Novel Therapeutics]